Announcements Trials

Browse Landscape

Phase

Status

Completed 33 Unknown 21 Not yet recruiting 6 Recruiting 4 Active not recruiting 4 Terminated 3 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Gemcitabine 6 Specimen Handling 5 Oxaliplatin 5 Irinotecan 5 S 1 (combination) 4 Leucovorin 4 Fluorouracil 4 Capecitabine 4 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Drug Therapy 3 Biopsy 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 titanium silicide 2 spartalizumab 2 lenvatinib 2 aldesleukin 2 Surgical Procedures, Operative 2 Photochemotherapy 2 Interleukin-2 2 Immunotherapy 2 Endoscopic Mucosal Resection 2 Cyclophosphamide 2 Cetuximab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vactosertib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Hepatectomy × Gastrointestinal × Clear all

NCT04840186 2024-11-12

EXCALIBUR3

Oslo University Hospital

Phase 2 Suspended

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡